Arterial stiffness, inflammatory and pro-atherogenic markers in gestational diabetes mellitus;Arteriensteifheit, entzändliche und proatherogene marker des gestationsdiabetes

Vasa - Journal of Vascular Diseases

Volumn 41, Issue 2, 2012, Pages 96-104

  Salmi, Ab A ^a   Zaki, Nik M N ^a   Zakaria, Rahimah ^a   Aliza, Abd G Nor ^a   Rasool, Aida H G ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Arterial stiffness; Gestational diabetes; High sensitivity C reactive protein; Inflammatory marker; Plasminogen activator inhibitor 1

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

AORTA PRESSURE; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; BODY MASS; BRACHIAL ARTERY; CAROTID ARTERY; CAROTID ARTERY PULSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; MEAN ARTERIAL PRESSURE; PREGNANCY DIABETES MELLITUS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PULSE WAVE;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; C-REACTIVE PROTEIN; CAROTID ARTERIES; CASE-CONTROL STUDIES; COMPLIANCE; CROSS-SECTIONAL STUDIES; DIABETES, GESTATIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMORAL ARTERY; GESTATIONAL AGE; GLUCOSE TOLERANCE TEST; HUMANS; INFLAMMATION MEDIATORS; MALAYSIA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES; PULSATILE FLOW; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84858604478     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526/a000171     Document Type: Article

References (30)

1. Anastasiou E, Lekakis J, Alevizaki M, Papamichael CM, Megas J, Souvatzoglou A, Stamatelopoulos SF. Impaired endothelium dependent vasodilatation in women with preious gestational diabetes. Diabetes Care 1998; 21: 2111-5.
2. Brooks B, Molyneaux L, Yue DK. Augmentation of central arterial pressure in Type 1 diabetes. Diabetes Care 1999; 22: 1122-7.
3. Carpenter MW and Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144: 768-73.
4. Catalano P, Kirwan P, Haugel-de Mouzon S, Kingz J. Gestational diabetes and insulin resistance: role in shortand long-term implications for mother and fetus. J Nutr 2003; 133: 1674-83.
5. Coughlan MT, Oliva K, Georgiou HM, Permezel JMH, Rice GE: Glucoseinduced release of tumor necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus. Diabet Med 2001; 18: 921-7.
6. Festa A, D'Agostino R, Mykkanen L, Tracy RP, Zaccaro DJ, Hales N, Haffner SM. Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance: The Insulin Resistance Atherosclerosis Study [IRAS] Arterioscler Thromb Vasc Biol 1999; 19: 562-8.
7. Heitritter SM, Solomon CG, Mitchell GF, Ounis NS, Seely EW: Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 2005; 90: 3983-8.
8. Idris N, Che Hatikah CH, Murizah MZ, Rushdan MN. Universal versus selective screening for detection of gestational diabetes mellitus in a Malaysian population. Malaysian Family Physician 2009; 4: 83-7.
9. Jie Hu, Mikael Norman, MP Wallensteen, Gerhard Gennser; Increased large arterial stiffness and impaired acetylcholine induced skin vasodilatation in women with previous gestational diabetes mellitus. Br J Obstet Gynaecol 1998; 105:1279-87.
10. Jovanovic L and Pettitt DJ. Gestational diabetes mellitus. JAMA. 2001; 286: 2516-8.
11. Khalil AA, Cooper DJ, Harrington KF. Pulse wave analysis: a preliminary study of a novel technique for the prediction of pre-eclampsia. Br J Obstet Gynaecol 2008; 116: 268-77.
12. Kirwan JP, Mouzon SH, Lepercq J, Challier JC, Presley LH, Friedman JE, Kalhan SC, Catalano PM. TNFalpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002; 51: 2207-13.
13. Lehmann ED, Gosling RG, Sönksen PH. Arterial wall compliance in diabetes. Diabet Med 1992; 9: 114-9.
14. Macaedo ML, Luminoso D, Savvidou MD, McEniery CM, Nicolaides KH. Maternal wave reflections and arterial stiffness in normal pregnancy as assessed by applanation tonometry. Hypertension 2008; 51: 1047-51.
15. McLachlan K, O'Neil D, Jenkins A, Alford FP. Do adiponectin, TNFα, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy. Diabetes Metab Rev 2006; 22: 131-8.
16. Metzger BE, Cho NH, Roston SM, Radvany R. Pre-pregnancy weight and anterpartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care 1993; 16: 1598-605.
17. O'Rouke MF and Gallagher DE. Pulse wave analysis. J Hypertens. 1996; 14: 147-57.
18. Oyama-Kato M, Ohmichi M, Takahashi K, Suzuki S, Henmi N, Yokoyama Y, Kurachi H. Change in pulse wave velocity throughout normal pregnancy and its value in predicting pregnancy-induced hypertension: A longitudinal study. Am J Obstet Gynecol 2006; 195: 464-9.
19. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. Creactive protein and gestational diabetes: The central role of maternal obesity. Clin Endocrinol Metab 2007; 88: 3507-12.
20. Robb AO, Mills NL, Din JN, Smith IB, Paterson F, Newby DE, Denison FC. Influence of the Menstrual Cycle, Pregnancy, and Preeclampsia on Arterial Stiffness. Hypertension 2009; 53: 952-8.
21. Rota S, Yildirim B, Kaleli B, Aybek H, Duman K, Kaptanoglu B. Creactive protein level in non-obese pregnant women with gestational diabetes. Tohoku J Exp Med 2005; 206: 341-5.
22. Safar ME, Czernichow S, and Blacher J. Obesity, Arterial Stiffness, and Cardiovascular Risk. J Am Soc Nephrol 2006; 17: 109-11.
23. Salmi AA, Nor Aliza AG, Nik Zaki NM, Wong AR, Aida HR. Older age group in pregnancy is associated with increased arterial stiffness. Med J Malaysia 2010; 65: 115-8.
24. Savvidou MD, Anderson JM, Kaihura C, Nicolaides KH. Maternal arterial stiffness in pregnancies complicated by gestational and type 2 diabetes mellitus. Am J Obstet Gynecol 2010; 203: 274-6.
25. Schalkwijk CG, Stehouwer CD: Vascular complications in diabetes mellitus: The role of endothelial dysfunction. Clin Sci. 2005; 109: 143-59.
26. Tihtonen KM, Koobi T, Uotila JT. Arterial stiffness in preeclamptic and chronic hypertensive pregnancies. J Obstet Gynecol 2006; 128: 180-6.
27. Winkler G, Cseh K, Baranyi E, Melczer Z, Speer G, Hajos P, Salamon F, Turi Z, Kavacs M, Vargha P, Karadi I. Tumor necrosis factor system in insulin resistance in gestational diabetes. Diabetes Res Clin Pract 2002; 56: 93-99.
28. Winzer C, Wagner O, Festa A, Schneider B, Roden M, BancherTodesca D, Pacini G, Funahachi T, Kautzky-Willer A. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 2004; 27: 1721-7.
29. Wolf M, Sandler L, Hsu K, VossenSmirnakis K, Ecker JL, Thadhani R. FirstTrimester C reactive protein and subsequent gestational diabetes. Diabetes Care 2003; 26: 819-24.
30. World Health Organization. Diabetes Mellitus: Report of a WHO Consultant. Definition, Diagnosis and Classification of diabetes mellitus and its complications, Part 1: Diagnosis and classification of diabetes mellitus. Geneva: WHO, 1999.